drugset / Trial / NCT05123820
Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470
NaSingle-groupOpen-labelOther
Summary
A study on whether ACT-1014-6470 has an effect on how the body takes up, distributes and gets rid of omeprazole and midazolam in healthy male subjects
Timeline
- Start
- 2021-11-13
- Primary completion
- 2021-11-24
- Completion
- 2021-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACT-1014-6470 | Unknown | 100 mg | Oral |
| Subject | Midazolam | Small molecule | 2 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 20 mg | Oral |
Indications
No indication recorded.